Geoffrey Uy (@Geoff_Uy) profile picture

Leukemia physician and researcher | Co-chair Leukemia Committee @ALLIANCE_org | Prof of Medicine @WUSTLMed @SitemanCenter

Saint Louis, Missouri
Joined April 2018
New publication! @alliance_org research led by Matthew Wiedewult MD of @WakeForest shows targeted immunotherapy drugs lead to high remission rates and long survival for patients with a tough-to-treat form of leukemia. bit.ly/Alliance-A041703-Coho… @JCO_ASCO #NCI
1
5
342
kudos to @DrWendyStock @CanerSaygin who are co-authors on a high-impact publication of Inotuzumab + blinatumomab in older adults with B-ALL! pubmed.ncbi.nlm.nih.gov/4102…
5
34
2,198
Testing for certain features in cancer (biomarkers) can tell doctors about what’s causing it to grow. The #myeloMATCH study uses advanced biomarker testing for adults with #AML or #MDS. @theNCI @ALLIANCE_org @CDNCancerTrials @eaonc @SWOG 1-800-4-CANCER or bit.ly/myeloMATCH
4
12
914
Congrats!! Can’t think of two better individuals to lead the @ALLIANCE_org Leukemia Correlative Science @mkonople and @Akeisfeld #leusm
Congratulations to @AkEisfeld (Ann-Kathrin Eisfeld, MD) @OSUCCC_James on her appointment as Alliance Leukemia Committee Correlative Science Vice-Chair! #AllianceSpring24 #NCI #NCTN #CancerResearch
4
317
For #TrialTuesday, .@LuskinMarlise @DanaFarber leads ALLIANCE_org A042001, a trial to compare targeted therapy & chemotherapy w/standard treatment for pts w/B-cell acute lymphoblastic #leukemia or B-cell lymphoblastic #lymphoma w/targeted therapy: bit.ly/Alliance-A042001 @LLSusa
3
6
694
Geoffrey Uy retweeted
E. Donnall Thomas lecturer @DiPersioLab introduces his lecture, "Is Transplantation Only Copacetic? A Personal Tale of Mentors, Trainees and Colleagues." Register for #Tandem24 & attend his lecture, taking place Feb. 23, 5:50 - 6:20 PM CT. Learn more: ow.ly/yhzX50QwZ6q
1
6
26
3,872
Please spread the message and help find these rare patients for this clinical trial for IDH1 mutated CCUS. The study is decentralized. Patients can be anywhere in the US and do not have to travel to St Louis to participate. #leusm
In 2021, @KellyLBolton and colleagues launched an unusual clinical study that not only evaluated one of the first potential genetically targeted preventative therapies for cancer, but may also help to reshape the future of clinical trials. Read more: bit.ly/3qkUkXr
2
9
2
22
6,192
Reach out to @KellyLBolton if you may have an eligible patient. classic.clinicaltrials.gov/c…
1
4
1,853
A true gentleman and leader.
Celebrating Dr. @MRLitzow at the @eaonc annual meeting. Mark led the #leukemia committee for 9 years, has contributed so much to improving treatment for pts with heme malignancies,& has been an incredible mentor and role model for so many of us. His dedication is unmatched.
7
460
Celebrating Dr. @MRLitzow at the @eaonc annual meeting. Mark led the #leukemia committee for 9 years, has contributed so much to improving treatment for pts with heme malignancies,& has been an incredible mentor and role model for so many of us. His dedication is unmatched.
4
4
1
57
5,564
This Post is from an account that no longer exists. Learn more
3
7
#ASH22 the ASH app needs a block / mute function on the chat.
3
#WUDeptMedicine announces new leadership for Division of Oncology. Read full announcement from Victoria Fraser, MD, Chair, Department of Medicine here: ow.ly/4uCQ50Lm4vG @WUSTLmed
2
7
23
A must read for clinical researchers in AML. A very thoughtful discussion by the FDA which addresses some subtle issues and ambiguities not covered by other groups such as ELN or NCCN.
Final @FDAOncology guidance on drug/biologic development in #AML! Check it out 👇! #leusm
2
Congrats to Tim. Proud to be count myself among your many trainees. @SitemanCenter @WUDeptMedicine
Replying to @ASH_hematology
🏆 Henry M. Stratton Medal: Timothy Ley, MD, @WUSTLmed & Robert Montgomery, MD, @MedicalCollege